The role of amines in the etiology of schizophrenia

https://doi.org/10.1016/S0010-440X(68)80051-3Get rights and content

First page preview

First page preview
Click to open first page preview

References (126)

  • ArmstrongM.D. et al.

    Biochem. Biophys. Acta

    (1957)
  • BourdillonR.E. et al.

    Nature

    (1965)
  • RandrupA. et al.
  • MunroT.A.

    Ann Engenies

    (1947)
  • BlumenthalM.D.

    J. Psychiat. Res.

    (1967)
  • KakimotoY. et al.

    J. Biol. Chem.

    (1962)
  • LevineR.J. et al.

    Life Sci.

    (1964)
  • AsatoorA.M. et al.

    Biochem. J.

    (1959)
  • BungeT.M. et al.

    J. Nerv. Ment. Dis.

    (1966)
  • de TourM.

    Du bachich et de l'alienation mentale

    (1845)
  • PrentissD.W. et al.

    Therap. Gaz.

    (1895)
  • Spacth

    Monatschr. f. Chemie

    (1918)
  • BeringerK.

    Der Meskalinrausch

    (1927)
  • de JongH.

    Experimental catatonia

    (1945)
  • de JongH. et al.

    La Catatonic Experimentale par la Bulbocapnina

    (1930)
  • de JongH.
  • NoteboomL.
  • Mayer-GrossW.

    Brit. Med. Journ.

    (1951)
  • OsmondH. et al.

    J. Ment. Sci.

    (1952)
  • HollisterL.E. et al.

    Nature

    (1966)
  • HofferA. et al.

    J. Ment. Sci.

    (1954)
  • OsmondH. et al.

    J. Ment. Sci.

    (1959)
  • SchwartzB.E. et al.

    Arch. Neur. Psychiat.

    (1956)
  • TaubmannG. et al.

    Nervenarzt.

    (1957)
  • Grof.S. et al.

    J. Neuropsychiat.

    (1963)
  • HofferA.

    Am. J. Psychiat.

    (1958)
  • SzáraS. et al.

    Am. J. Psychiat.

    (1958)
  • RandrupA. et al.

    Am. J. Psychiat.

    (1960)
  • FeldsteinA.

    Am. J. Psychiat.

    (1959)
  • AxelrodJ. et al.

    J. Biol. Chem.

    (1959)
  • AxelrodJ.

    Physiol. Rev.

    (1959)
  • BergsmanA.

    Acta Psychiat. et Neurol. Scand.,

    (1959)
  • MannJ.D. et al.

    Arch. Gen. Psychiat.

    (1959)
  • PindK. et al.

    Scand. J. Clin. Lab. Investig.

    (1961)
  • La BrosseE.H. et al.

    J. Psychiat. Research

    (1963)
  • FriedhoffA.J. et al.

    Nature

    (1962)

    J. Nerv. Ment. Dis.

    (1962)
  • FriedhoffA.J. et al.

    Nature

    (1963)
  • Friedhoff, J. A., and Van Winkle, E.: Page 19 in “Amines and Schizophrenia” ed. by Himwich. Kety &...
  • FriedhollA.J. et al.

    Nature

    (1967)
  • KuehlF.A. et al.

    Nature

    (1964)
  • SenN.P. et al.

    Biophys. Res. Commun.

    (1964)
  • TakesadaM. et al.

    Nature

    (1963)
  • StudnitzW.Von et al.

    Acta Psychiat. Scand.

    (1965)
  • PerryTh.L. et al.

    Nature

    (1964)
  • FaurbyeA. et al.

    Acta Psychiat. Scand.

    (1964)
  • FaurbyeA. et al.
  • FaurbyeA. et al.

    Acta psychiat. scand.

    (1966)
  • NishimuraT. et al.

    Nature

    (1965)
  • PindK. et al.

    Acta psych. scand.

    (1966)
  • WilliamsC.H. et al.

    Nature

    (1966)
  • Cited by (35)

    • Animal models of schizophrenia: Emphasizing construct validity

      2012, Progress in Molecular Biology and Translational Science
      Citation Excerpt :

      Moreover, rhesus monkey behaviors generated by subchronic amphetamine suggest hallucinatory phenomena.10 The putative mechanism of this psychotomimetic action, postulated as a dopamine-mediated phenomenon, fits scientifically into the early hypothesis of schizophrenia as a disease of dopamine hyperactivity,56 an idea based primarily on the antidopaminergic action of antipsychotic medications. Therefore, amphetamine and other direct and indirect dopamine agonists, like apomorphine, were used in animal models to screen early antipsychotic drugs for antipsychotic action.

    • The Dopamine System and the Pathophysiology of Schizophrenia: A Basic Science Perspective

      2007, International Review of Neurobiology
      Citation Excerpt :

      Therefore, DA is now considered to be a neuromodulator. The reason for this substantial level of interest is due to its involvement in a number of neurological and psychiatric disorders including Parkinson's disease (Hornykiewicz, 1971; Lloyd and Hornykiewicz, 1970) and schizophrenia (Faurbye, 1968; Fischer, 1970). The loss of DA neurons in the nigrostriatal system has been shown to underlie the symptoms of Parkinson's disease (Hornykiewicz, 1971; Lloyd and Hornykiewicz, 1970), whereas excessive DA release has been suggested in the pathophysiology of schizophrenia.

    View all citing articles on Scopus
    View full text